Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Leaf

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
American Journal of Physiology. Renal Physiology|August 19, 2016
Catalytic iron and acute kidney injuryDavid E Leaf, Dorine W Swinkels
Critical Care Medicine|March 29, 2021
Questioning the Futility of Cardiopulmonary Resuscitation in Patients With Severe Coronavirus Disease 2019David E Leaf, Salim S Hayek
Clinical Journal of the American Society of Nephrology : CJASN|April 7, 2023
Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19: The End of the Beginning?Osman A Yilmam, David E Leaf
The New England Journal of Medicine|December 28, 2020
Tocilizumab in Covid-19David E Leaf, Shruti Gupta, Wei Wang
Intensive Care Medicine|March 19, 2026
Acute kidney injury and chronic kidney disease in the aging critically ill patientStéphane Gaudry, David E Leaf, Bertrand Guidet
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injuryDavid E Leaf, Myles Wolf, Leonard Stern
The New England Journal of Medicine|May 28, 2020
Soluble Urokinase Receptor and Acute Kidney Injury. ReplySalim S Hayek, David E Leaf, Jochen Reiser
JAMA|December 12, 2022
Target Trial Emulation: A Framework for Causal Inference From Observational DataMiguel A Hernán, Wei Wang, David E Leaf
Kidney International|June 4, 2010
Glomerular disease: why is there a dearth of high quality clinical trials?David E Leaf, Gerald B Appel, Jai Radhakrishnan
Chest|January 19, 2010
Relationship between ICU design and mortalityDavid E Leaf, Peter Homel, Phillip H Factor
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
American Journal of Physiology. Renal Physiology|August 19, 2016
Catalytic iron and acute kidney injuryDavid E Leaf, Dorine W Swinkels
Critical Care Medicine|March 29, 2021
Questioning the Futility of Cardiopulmonary Resuscitation in Patients With Severe Coronavirus Disease 2019David E Leaf, Salim S Hayek
Clinical Journal of the American Society of Nephrology : CJASN|April 7, 2023
Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19: The End of the Beginning?Osman A Yilmam, David E Leaf
The New England Journal of Medicine|December 28, 2020
Tocilizumab in Covid-19David E Leaf, Shruti Gupta, Wei Wang
Intensive Care Medicine|March 19, 2026
Acute kidney injury and chronic kidney disease in the aging critically ill patientStéphane Gaudry, David E Leaf, Bertrand Guidet
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injuryDavid E Leaf, Myles Wolf, Leonard Stern
The New England Journal of Medicine|May 28, 2020
Soluble Urokinase Receptor and Acute Kidney Injury. ReplySalim S Hayek, David E Leaf, Jochen Reiser
JAMA|December 12, 2022
Target Trial Emulation: A Framework for Causal Inference From Observational DataMiguel A Hernán, Wei Wang, David E Leaf
Kidney International|June 4, 2010
Glomerular disease: why is there a dearth of high quality clinical trials?David E Leaf, Gerald B Appel, Jai Radhakrishnan
Chest|January 19, 2010
Relationship between ICU design and mortalityDavid E Leaf, Peter Homel, Phillip H Factor
Pageof 17